Literature DB >> 15033882

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.

Patricia Yudkin1, Marcus Munafò, Kate Hey, Sarah Roberts, Sarah Welch, Elaine Johnstone, Michael Murphy, Siân Griffiths, Robert Walton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033882      PMCID: PMC404497          DOI: 10.1136/bmj.38050.674826.AE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Randomised trial of nicotine patches in general practice: results at one year. Imperial Cancer Research Fund General Practice Research Group.

Authors: 
Journal:  BMJ       Date:  1994-06-04

Review 2.  Sex differences in nicotine effects and self-administration: review of human and animal evidence.

Authors:  K A Perkins; E Donny; A R Caggiula
Journal:  Nicotine Tob Res       Date:  1999-12       Impact factor: 4.244

3.  Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.

Authors:  Elaine C Johnstone; Patricia L Yudkin; Kate Hey; Sarah J Roberts; Sarah J Welch; Michael F Murphy; Siân E Griffiths; Robert T Walton
Journal:  Pharmacogenetics       Date:  2004-02

4.  The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking.

Authors:  D E Comings; L Ferry; S Bradshaw-Robinson; R Burchette; C Chiu; D Muhleman
Journal:  Pharmacogenetics       Date:  1996-02

5.  D2 dopamine receptor gene and cigarette smoking: a reward gene?

Authors:  E P Noble; S T St Jeor; T Ritchie; K Syndulko; S C St Jeor; R J Fitch; R L Brunner; R S Sparkes
Journal:  Med Hypotheses       Date:  1994-04       Impact factor: 1.538

  5 in total
  37 in total

Review 1.  Genetics and smoking cessation improving outcomes in smokers at risk.

Authors:  Caryn E Lerman; Robert A Schnoll; Marcus R Munafò
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

2.  The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.

Authors:  Sean P David; Marcus R Munafò; Michael F G Murphy; Robert T Walton; Elaine C Johnstone
Journal:  Nicotine Tob Res       Date:  2007-02       Impact factor: 4.244

Review 3.  Genetics and smoking behavior.

Authors:  Robert A Schnoll; Terrance A Johnson; Caryn Lerman
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

4.  Genetic epidemiology and primary care.

Authors:  Blair H Smith; Graham C M Watt; Harry Campbell; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2006-03       Impact factor: 5.386

Review 5.  Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.

Authors:  Marcus R Munafò; Nicholas J Timpson; Sean P David; Shah Ebrahim; Debbie A Lawlor
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

6.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

7.  CHRNA3 rs1051730 genotype and short-term smoking cessation.

Authors:  Marcus R Munafò; Elaine C Johnstone; Donna Walther; George R Uhl; Michael F G Murphy; Paul Aveyard
Journal:  Nicotine Tob Res       Date:  2011-06-20       Impact factor: 4.244

Review 8.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 9.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 10.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.